185 related articles for article (PubMed ID: 16203286)
21. Primary adenoid cystic carcinoma of the lung: absence of KIT mutations.
Aubry MC; Heinrich MC; Molina J; Lewis JE; Yang P; Cassivi SD; Corless CL
Cancer; 2007 Dec; 110(11):2507-10. PubMed ID: 17932891
[TBL] [Abstract][Full Text] [Related]
22. Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast.
Mastropasqua MG; Maiorano E; Pruneri G; Orvieto E; Mazzarol G; Vento AR; Viale G
Mod Pathol; 2005 Oct; 18(10):1277-82. PubMed ID: 15846389
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
24. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
25. KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas.
Pan CC; Chen PC; Chiang H
J Pathol; 2004 Mar; 202(3):375-81. PubMed ID: 14991904
[TBL] [Abstract][Full Text] [Related]
26. Thymic basaloid carcinoma: a clinicopathologic study of 12 cases, with a general discussion of basaloid carcinoma and its relationship with adenoid cystic carcinoma.
Brown JG; Familiari U; Papotti M; Rosai J
Am J Surg Pathol; 2009 Aug; 33(8):1113-24. PubMed ID: 19461509
[TBL] [Abstract][Full Text] [Related]
27. A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands.
Pfeffer MR; Talmi Y; Catane R; Symon Z; Yosepovitch A; Levitt M
Oral Oncol; 2007 Jan; 43(1):33-6. PubMed ID: 16757202
[TBL] [Abstract][Full Text] [Related]
28. Cylindroma (dermal analog tumor) of the breast: a comparison with cylindroma of the skin and adenoid cystic carcinoma of the breast.
Albores-Saavedra J; Heard SC; McLaren B; Kamino H; Witkiewicz AK
Am J Clin Pathol; 2005 Jun; 123(6):866-73. PubMed ID: 15899777
[TBL] [Abstract][Full Text] [Related]
29. Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland.
Freier K; Flechtenmacher C; Walch A; Devens F; Mühling J; Lichter P; Joos S; Hofele C
Oral Oncol; 2005 Oct; 41(9):934-9. PubMed ID: 16054424
[TBL] [Abstract][Full Text] [Related]
30. [Adenoid basal carcinoma and adenoid cystic carcinoma of the uterine cervix].
Lefrancq T; de Muret A; Michalak S; Lhuintre Y; Fetissof F
Ann Pathol; 1997 Jul; 17(3):196-9. PubMed ID: 9296580
[TBL] [Abstract][Full Text] [Related]
31. Is c-kit (CD117) immunolocalization in cell block preparations useful in the differentiation of adenoid cystic carcinoma from pleomorphic adenoma?
Chandan VS; Wilbur D; Faquin WC; Khurana KK
Cancer; 2004 Aug; 102(4):207-9. PubMed ID: 15368311
[No Abstract] [Full Text] [Related]
32. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract][Full Text] [Related]
33. Thymic tumor with adenoid cystic carcinomalike features: a clinicopathologic study of 4 cases.
Di Tommaso L; Kuhn E; Kurrer M; Zettl A; Marx A; Müller-Hermelink HK; Roncalli M; Rosai J
Am J Surg Pathol; 2007 Aug; 31(8):1161-7. PubMed ID: 17667537
[TBL] [Abstract][Full Text] [Related]
34. Metallothionein immunostaining in adenoid cystic carcinomas of the salivary glands.
Alves SM; Cardoso SV; de Fátima Bernardes V; Machado VC; Mesquita RA; Vieira do Carmo MA; Ferreira Aguiar MC
Oral Oncol; 2007 Mar; 43(3):252-6. PubMed ID: 16857408
[TBL] [Abstract][Full Text] [Related]
35. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
[TBL] [Abstract][Full Text] [Related]
36. Adenoid cystic carcinoma of the breast.
Hopkins GB; Tullis RH
Calif Med; 1972 Oct; 117(4):9-11. PubMed ID: 4342448
[TBL] [Abstract][Full Text] [Related]
37. [Protein expression of p53, bcl-2, and bax in adenoid cystic carcinoma of lacrimal gland].
You JQ; Wang P
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1978-82. PubMed ID: 19062739
[TBL] [Abstract][Full Text] [Related]
38. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
[TBL] [Abstract][Full Text] [Related]
39. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
[TBL] [Abstract][Full Text] [Related]
40. Expression of miRNAs in adenoid cystic carcinomas of the breast and salivary glands.
Kiss O; Tőkés AM; Vranic S; Gatalica Z; Vass L; Udvarhelyi N; Szász AM; Kulka J
Virchows Arch; 2015 Nov; 467(5):551-62. PubMed ID: 26293217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
